Find our latest guidance and information on coronavirus (COVID-19)

Dismiss

Clopidogrel / PPI interaction

In May 2009, the EU Committee for Medicinal products for Human Use (CHMP) concluded that concomitant use of any Proton Pump Inhibitor (PPI) with clopidogrel should be avoided unless considered essential.

This was based on pharmacokinetic, pharmacodynamic, and some clinical outcome data, which demonstrated that omeprazole competitively inhibits the

CYP2C19 isoenzyme (which metabolises clopidogrel to its active metabolite); reduces the ability of clopidogrel to inhibit platelet aggregation; and reduces the beneficial effect of

clopidogrel in patients.

Download Clopidogrel / PPI interaction PDF - 242.0 KB
Back to top
BEST CARE FOR EVERYONE

We use cookies to provide you with a better service. Carry on browsing if you’re happy with this or read more about our cookie policy and privacy policy.

Dismiss